Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

Impact · against what's priced in

Movado Group is generating a $66.5 million cash influx by divesting a 95% stake in the EBEL brand. This provides an immediate balance sheet boost and increases capital flexibility.

MOV+0.40: No priced-in read yet
In context: The sale of a 95% interest in EBEL for $66.5 million provides a direct cash injection and alters the company's brand portfolio.
Read from the article alone
Actual

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

luxury goods▲167%
m and a
MOV
acquisition
divestiture
watches

Top 1 mover · tap to explore

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

What matters in this story

Informa's Clarion deal to strengthen events lead and lift growth, says Panmure Liberum

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

What matters in this story

Informa's Clarion deal to strengthen events lead and lift growth, says Panmure Liberum

How each ticker is affected

Track these names every morning.

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

U.K. Regulator Says Brink's Disposals Could Clear Way for $4 Billion NCR Atleos Takeover

Intermap Completes Acquisition of PCI Geomatics

SCHW's Planned Forge Trust Sale to Boost Its Private Market Strategy?

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

What matters in this story

Next reads from the same story arc

Informa's Clarion deal to strengthen events lead and lift growth, says Panmure Liberum

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

What matters in this story

Next reads from the same story arc

Informa's Clarion deal to strengthen events lead and lift growth, says Panmure Liberum

How each ticker is affected

Track these names every morning.

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

U.K. Regulator Says Brink's Disposals Could Clear Way for $4 Billion NCR Atleos Takeover

Intermap Completes Acquisition of PCI Geomatics

SCHW's Planned Forge Trust Sale to Boost Its Private Market Strategy?